Authors
Latest:
Melphalan Flufenamide for Relapsed or Refractory Multiple MyelomaMelphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
Latest:
Thriving in a Digital World: Marketing Strategies for Independent PharmaciesCut through the online noise with these digital marketing tips for your independent pharmacy.
Latest:
Q&A: Pharmacists’ Understanding of CKD Therapies, Adverse Effects | ASHP MidyearDenise Kelley, PharmD, BCPS, FASHP, joined Drug Topics to discuss various medications for chronic kidney disease and their common adverse reactions.
Latest:
New Data Shows Cebranopadol’s Potential in Acute Pain ManagementA conversation with Todd Bertoch, MD, chief medical officer for pain research at CenExel and an investigator on the ALLEVIATE-2 trial.
Latest:
Cannabinoid Hyperemesis Syndrome: Diagnosis and ManagementA deep dive for pharmacists into this frequently debilitating disorder
Latest:
The Unique Challenges, Growth in the Business of Health-System PharmacyFrom market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.
Latest:
Best Practices on Discussing Birth Control for AdolescentsThere are numerous methods of contraception available for adolescents.
Latest:
Q&A: Building a Better Future for Community PharmacyJennifer Bacci, PharmD, MPH, discusses ways to improve current issues impacting community pharmacy.
Latest:
The Evolution of PharmacogenomicsPharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.
Latest:
Symptom Scoring Framework Helps Formalize Definition of Long COVIDFinalizing a definition for postacute sequelae of SARS-CoV-2 infection will lead to high-quality care and treatment for patients suffering from the condition.
Latest:
National Pharmacy Chain Opioid Settlements Poised to Affect Independent PharmaciesStipulations of the settlements include data reporting, annual training, and an independent compliance officer.
Latest:
Understanding What Vaccines Could Mean for Long COVIDResearch suggests that COVID-19 vaccination may serve a therapeutic effect, possibly reducing the risk of developing long COVID when administered to those currently infected.
Latest:
Probiotics for the Prevention of Pediatric Antibiotic-Associated DiarrheaEvidence of the relationship between probiotics and antibiotics is lacking.
Latest:
FDA, CDC Increase Availability of RSV Monoclonal Antibody for InfantsThe federal agencies said that they will continue to work closely with manufacturers to maintain the availability of the vaccines through the end of 2023 and early 2024 to meet the demand during the RSV season.
Latest:
Recap: Pharmacists Share The Biggest Takeaways from APhA 2025Experts discuss what they learned at the American Pharmacists Association Annual Meeting and Exposition 2025.
Latest:
What is Being Done to Address Pharmacy Deserts in the US?Cencora representatives with expertise into pharmacy desert insights joined Drug Topics to discuss issues in pharmacy access and what is being done to address them.
Latest:
Rite Aid to Sell Pharmacy Assets From Over 1,000 Stores to CVS, WalgreensThe announcement comes shortly after the company announced it had filed its second chapter 11 bankruptcy in under 2 years.
Latest:
FDA: CBD Requires Separate Regulatory Pathway from Dietary Supplements, FoodThe agency intends to work with Congress to create a pathway that balances the desire for access with regulatory oversight and risk management.
Latest:
How Pharmacies Can Help Move Health Equity ForwardAs costs increase and the number of people in need further outpaces resources, it becomes increasingly urgent to find ways to further extend services to the people who need them.
Latest:
Early CT Screening Linked to Improved Lung Cancer SurvivalAlthough early computed tomography (CT) screening was associated with improved cure rate for patients with lung cancer, less than 6% of the population that is eligible receives it.
Latest:
FDA Approves Oral Treatment for Postpartum DepressionLast August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.
Latest:
Pediatric Vaccines Strongly Recommended, Study ShowsNot every vaccine is required, some are just strongly recommended. Here's what to know about 5 recommended vaccines.
Latest:
Breaking: Benzene Found in Acne Products From Major Brands, Prompts FDA Recall PetitionFollowing investigation by the independent testing laboratory, Valisure found acne products that contain up to 12 times the allowed of benzene.
Latest:
NCPA's New Consortium Exemplifies Preparedness in Community PharmacyThe new initiative is a way for NCPA to proactively engage its network of community pharmacies during a potential public health crisis.
Latest:
College Students and Misuse of SubstancesThe prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.
Latest:
Methotrexate, Leflunomide Linked to Higher Risk of Adverse Pregnancy Outcomes in Patients With RADue to the increased possibility of adverse pregnancy outcomes associated with methotrexate and leflunomid, it is crucial that patients with rheumatoid arthritis (RA) engage in thorough consultations with their physicians regarding pregnancy planning.
Latest:
Insomnia and Bipolar Disorder: New DirectionsThe average patient with bipolar disorder struggles with sleep disorders. Here's how you can help.
Latest:
Improve Patient Care and Chronic Disease ManagementHealthcare professionals need to make patients the primary decision-makers in their own care and actively support their efforts to achieve their care goals.
Latest:
The Good, The Bad, and the Missed Opportunity of Mark Cuban Cost Plus Drug CompanyThe billionaire’s first venture into pharmacy launched earlier this year.
Latest:
Why Artificial Intelligence is Critical to the Success of Value-Based CareEmploying AI-driven technology ensures accurate and timely compliance with industry regulations, mitigates audits and fines, and helps forecast accurate reimbursements.
